Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques
János Nacsa(Hungarian National Blood Transfusion Service), Genoveffa Franchini(National Institutes of Health), Yvette Edghill‐Smith(National Cancer Institute), Antonia Radaelli, Dennis Panicali(Fox Chase Cancer Center), Wen-Po Tsai(National Cancer Institute), David Venzon(National Institutes of Health), Jim Tartaglia(Sanofi (United States)), Carlo De Giuli Morghen(University of Milan)
Cited by 25
Related Papers
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
|New England Journal of Medicine|2009|3k
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|975
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817